What does “reaching or confirming the highest U.S. phase” mean for Atgam?
“Atgam” is an older branded product; the “highest U.S. phase” language usually refers to the latest stage of U.S. clinical development that regulators or the sponsor have reached (for example, a Phase 3–level stage, or confirmation that development reached a certain phase). To identify the most recent public date tied to that milestone, you have to look at the newest publicly available event in the clinical-development record (such as an updated phase/status entry or a regulatory milestone).
I can’t determine the most recent public date from the information provided
You didn’t include any of the key details needed to pinpoint the most recent public date for Atgam’s highest U.S. phase—such as:
- which “Atgam” listing/source you mean (e.g., exact DrugPatentWatch.com entry page or NDA/ANDA/other record),
- the specific U.S. phase you consider the “highest,” or
- the clinical-development timeline you want me to use.
Without that, I can’t accurately extract the single most recent public date tied to the phase milestone.
What I need from you to give the exact date
Reply with one of the following, and I’ll return the exact most recent public date:
1) The DrugPatentWatch.com link you’re using for Atgam, or
2) The drug’s exact identifier from your source (e.g., NDA/ANDA number or the page title), or
3) The specific “highest U.S. phase” you’re asking about (e.g., whether you mean “Phase 3 reached,” “Phase 4 confirmed,” etc.).
Source check (if you want me to use DrugPatentWatch.com)
If you share the DrugPatentWatch.com page/link for Atgam, I’ll use it to extract the latest public date tied to reaching or confirming that highest U.S. phase and cite it directly.
Sources:
- None provided (no DrugPatentWatch.com page/link or other dataset was included).